Glaxosmithkline Peps Up On Dpco Hopes

GlaxoSmithKline (GSK) Pharma can benefit largely from the anticipated new Drug Price Control Order and this has the market rooting for the scrip. In fact, good market support saw the scrip of the pharma MNC gain 1.26 per cent to Rs 302.25 on the Bombay Stock Exchange (BSE) in the late afternoon trades.

However at close, the scrip fell by 0.84 per cent to Rs 296. The scrip moved between a low of Rs 297.45 and a high of Rs 304.80. A total of 44,594 shares changed hands on the BSE today.

The scrip has now risen 9.43 per cent to its current levels from its 52-week low of Rs 276.20 on 17 February 2003. In the 10 prior months, the scrip lost 38 per cent to its 52-week low from its 52-week high of Rs 445 on April 18, 2002.

Special dividend buzz buoys Hindustan Lever

Hindustan Lever (HLL) was the scene of action today as marketmen speculated that the company may come out with a special dividend if dividend tax is abolished in the forthcoming budget. The scrip closed at Rs 172.60, up by 0.79 per cent on the Bombay Stock Exchange.

In early afternoon trades, the scrip gained 0.85 per cent to Rs 172.20. It, however, came off the day